Coverage
-
January 04, 2012
Abbott Laboratories on Tuesday dropped five consolidated patent infringement suits against Teva Pharmaceuticals Industries Ltd. over Teva's attempts to market a generic version of Abbott's cholesterol drug Simcor.
1 other articles on this case.
View all »